Literature DB >> 25661194

Differential alteration in peripheral T-regulatory and T-effector cells with change in P-glycoprotein expression in Childhood Nephrotic Syndrome: A longitudinal study.

Narayan Prasad1, Akhilesh K Jaiswal2, Vikas Agarwal3, Brijesh Yadav2, Raj Kumar Sharma2, Mohit Rai3, Harshit Singh3, Saurabh Chaturvedi3, Ajay Singh2.   

Abstract

INTRODUCTION: Childhood Idiopathic Nephrotic Syndrome (INS) responds to glucocorticoid therapy, however, 60-80% of patients relapse and some of them become steroid non responsive. INS may occur because of T cell dysfunction, abnormal cytokines and podocytopathies which reverse on steroid treatment. The reason of relapses could be imbalances in T cells phenotypes and respective cytokines. Herein, we hypothesize that relapses in INS may occur due to imbalance in T-regulatory and T-effector cell with their respective cytokines and overexpression of P-gp on lymphocytes.
METHODS: The frequency of peripheral blood CD4(+)CD25(+)FoxP3(+) Treg, CD4(+)IFN-γ(+) Th1 and CD4(+)IL-4(+) Th2 lymphocytes and their respective cytokines and P-gp expression on peripheral blood lymphocytes (PBLs) were analyzed in INS patients at baseline (n=26), during remission (n=24) and at relapse (n=15).
RESULTS: Compared to baseline, the frequency of Tregs was significantly increased at remission and decreased during relapse. In contrast, the frequency of Th1 and Th2 lymphocytes was significantly decreased during remission and increased at the time of relapse. Similarly, expression of P-gp was significantly high at baseline and at the time of relapse as compared to remission. Levels of cytokines IL-10 and TGF-β in the supernatant of stimulated PBMCs was increased during remission and decreased during relapse. In contrast, levels of IFN-γ and IL-4 were decreased during remission and increased at the time of relapse.
CONCLUSIONS: Steroid therapy in INS induces decreased P-gp expression on PBLs along with increased frequency and cytokine response of T-regulatory cells, and reduced frequency and respective cytokine response of Th1 and Th2 cells during remission. However, reversal in the frequency and respective cytokines of T-regs, Th1 and Th2, and P-gp expression on PBLs occurs during relapses on follow-up.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Effector T cells; Nephrotic Syndrome; P-gp expression; Regulatory T cells; Relapse

Mesh:

Substances:

Year:  2015        PMID: 25661194     DOI: 10.1016/j.cyto.2014.12.028

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  20 in total

1.  NOX-mediated impairment of PDGF-induced DNA synthesis in peripheral blood lymphocytes of children with idiopathic nephrotic syndrome.

Authors:  Amal Al-Eisa; Gursev S Dhaunsi
Journal:  Pediatr Res       Date:  2017-06-14       Impact factor: 3.756

Review 2.  Minimal change disease and idiopathic FSGS: manifestations of the same disease.

Authors:  Rutger J Maas; Jeroen K Deegens; Bart Smeets; Marcus J Moeller; Jack F Wetzels
Journal:  Nat Rev Nephrol       Date:  2016-10-17       Impact factor: 28.314

3.  Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletion.

Authors:  Mai Sato; Koichi Kamei; Masao Ogura; Kenji Ishikura; Shuichi Ito
Journal:  Clin Exp Nephrol       Date:  2017-04-22       Impact factor: 2.801

4.  P-Glycoprotein Activity in Steroid-Responsive vs. Steroid-Resistant Nephrotic Syndrome.

Authors:  Hassan S Badr; Mahmoud A El-Hawy; Mohammed A Helwa
Journal:  Indian J Pediatr       Date:  2016-05-19       Impact factor: 1.967

5.  Clinical Significance of Probiotics for Children with Idiopathic Nephrotic Syndrome.

Authors:  Tadashi Yamaguchi; Shoji Tsuji; Shohei Akagawa; Yuko Akagawa; Jiro Kino; Sohsaku Yamanouchi; Takahisa Kimata; Masaki Hashiyada; Atsushi Akane; Kazunari Kaneko
Journal:  Nutrients       Date:  2021-01-26       Impact factor: 5.717

6.  Serum levels of P-glycoprotein and persistence of disease activity despite treatment in patients with systemic lupus erythematosus.

Authors:  Edsaul Emilio Perez-Guerrero; Jorge Ivan Gamez-Nava; Jose Francisco Muñoz-Valle; Ernesto German Cardona-Muñoz; David Bonilla-Lara; Nicte Selene Fajardo-Robledo; Arnulfo Hernan Nava-Zavala; Teresa Arcelia Garcia-Cobian; Ana Rosa Rincón-Sánchez; Jessica Daniela Murillo-Vazquez; David Cardona-Müller; Maria Luisa Vazquez-Villegas; Sylvia Elena Totsuka-Sutto; Laura Gonzalez-Lopez
Journal:  Clin Exp Med       Date:  2017-02-27       Impact factor: 5.057

Review 7.  Pathogenesis of minimal change nephrotic syndrome: an immunological concept.

Authors:  Seong Heon Kim; Se Jin Park; Kyoung Hee Han; Andreas Kronbichler; Moin A Saleem; Jun Oh; Beom Jin Lim; Jae Il Shin
Journal:  Korean J Pediatr       Date:  2016-05-31

Review 8.  Immunologic Changes Implicated in the Pathogenesis of Focal Segmental Glomerulosclerosis.

Authors:  Andreas Kronbichler; Johannes Leierer; Jun Oh; Björn Meijers; Jae Il Shin
Journal:  Biomed Res Int       Date:  2016-02-17       Impact factor: 3.411

Review 9.  Rituximab in Minimal Change Disease: Mechanisms of Action and Hypotheses for Future Studies.

Authors:  Nima Madanchi; Martin Bitzan; Tomoko Takano
Journal:  Can J Kidney Health Dis       Date:  2017-03-13

Review 10.  Long-term Outcomes of Childhood Onset Nephrotic Syndrome.

Authors:  Rebecca Hjorten; Zohra Anwar; Kimberly Jean Reidy
Journal:  Front Pediatr       Date:  2016-05-25       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.